FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902060873> ?p ?o ?g. }

• W2902060873 endingPage "e0203874" @default.
• W2902060873 startingPage "e0203874" @default.
• W2902060873 abstract "Oxidative stress is believed to be a major driver of inflammation in smoking asthmatics. The U-BIOPRED project recruited a cohort of Severe Asthma smokers/ex-smokers (SAs/ex) and non-smokers (SAn) with extensive clinical and biomarker information enabling characterization of these subjects. We investigated oxidative stress in severe asthma subjects by analysing urinary 8-iso-PGF2α and the mRNA-expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways of SAs/ex and SAn. All the severe asthma U-BIOPRED subjects were further divided into current smokers with severe asthma (CSA), ex-smokers with severe asthma (ESA) and non-smokers with severe asthma (NSA) to deepen the effect of active smoking. Clinical data, urine and sputum were obtained from severe asthma subjects. A bronchoscopy to obtain bronchial biopsy and brushing was performed in a subset of subjects. The main clinical data were analysed for each subset of subjects (urine-8-iso-PGF2α; IS-transcriptomics; BB-transcriptomics; BBr-transcriptomics). Urinary 8-iso-PGF2α was quantified using mass spectrometry. Sputum, bronchial biopsy and bronchial brushing were processed for mRNA expression microarray analysis. Urinary 8-iso-PGF2α was increased in SAs/ex, median (IQR) = 31.7 (24.5–44.7) ng/mmol creatinine, compared to SAn, median (IQR) = 26.6 (19.6–36.6) ng/mmol creatinine (p< 0.001), and in CSA, median (IQR) = 34.25 (24.4–47.7), vs. ESA, median (IQR) = 29.4 (22.3–40.5), and NSA, median (IQR) = 26.5 (19.6–16.6) ng/mmol creatinine (p = 0.004). Sputum mRNA expression of NOX2 was increased in SAs/ex compared to SAn (probe sets 203922_PM_s_at fold-change = 1.05 p = 0.006; 203923_PM_s_at fold-change = 1.06, p = 0.003; 233538_PM_s_at fold-change = 1.06, p = 0.014). The mRNA expression of antioxidant enzymes were similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in bronchial brushing of SAs/ex compared to SAn (fold-change = -1.10; p = 0.029). NOS2 mRNA expression in bronchial brushing correlated with FeNO (Kendal’s Tau = 0.535; p< 0.001). From clinical and inflammatory analysis, FeNO was lower in CSA than in ESA in all the analysed subject subsets (p< 0.01) indicating an effect of active smoking. Results about FeNO suggest its clinical limitation, as inflammation biomarker, in severe asthma active smokers. These data provide evidence of greater systemic oxidative stress in severe asthma smokers as reflected by a significant changes of NOX2 mRNA expression in the airways, together with elevated urinary 8-iso-PGF2α in the smokers/ex-smokers group. Trial registration ClinicalTrials.gov—Identifier: NCT01976767" @default.
• W2902060873 created "2018-12-11" @default.
• W2902060873 creator A5000092448 @default.
• W2902060873 creator A5000373583 @default.
• W2902060873 creator A5012287816 @default.
• W2902060873 creator A5013346591 @default.
• W2902060873 creator A5014751113 @default.
• W2902060873 creator A5015443776 @default.
• W2902060873 creator A5020332377 @default.
• W2902060873 creator A5020511030 @default.
• W2902060873 creator A5021762566 @default.
• W2902060873 creator A5030238684 @default.
• W2902060873 creator A5031564190 @default.
• W2902060873 creator A5032624229 @default.
• W2902060873 creator A5033685470 @default.
• W2902060873 creator A5035270690 @default.
• W2902060873 creator A5036414874 @default.
• W2902060873 creator A5041071402 @default.
• W2902060873 creator A5043576559 @default.
• W2902060873 creator A5044179945 @default.
• W2902060873 creator A5044455625 @default.
• W2902060873 creator A5047985554 @default.
• W2902060873 creator A5052796561 @default.
• W2902060873 creator A5055008823 @default.
• W2902060873 creator A5056150470 @default.
• W2902060873 creator A5060510125 @default.
• W2902060873 creator A5063587197 @default.
• W2902060873 creator A5064055707 @default.
• W2902060873 creator A5066281730 @default.
• W2902060873 creator A5068864839 @default.
• W2902060873 creator A5073019940 @default.
• W2902060873 creator A5081300602 @default.
• W2902060873 creator A5081302632 @default.
• W2902060873 creator A5083447947 @default.
• W2902060873 date "2018-09-21" @default.
• W2902060873 modified "2023-10-13" @default.
• W2902060873 title "Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort" @default.
• W2902060873 cites W130086341 @default.
• W2902060873 cites W1549999213 @default.
• W2902060873 cites W1580883143 @default.
• W2902060873 cites W1966897185 @default.
• W2902060873 cites W1967468829 @default.
• W2902060873 cites W1974840884 @default.
• W2902060873 cites W1975813709 @default.
• W2902060873 cites W1976272009 @default.
• W2902060873 cites W1981266696 @default.
• W2902060873 cites W1983754228 @default.
• W2902060873 cites W1992270428 @default.
• W2902060873 cites W1996024251 @default.
• W2902060873 cites W1996772389 @default.
• W2902060873 cites W2006875202 @default.
• W2902060873 cites W2013105339 @default.
• W2902060873 cites W2018432392 @default.
• W2902060873 cites W2038371644 @default.
• W2902060873 cites W2040866973 @default.
• W2902060873 cites W2052122855 @default.
• W2902060873 cites W2053324714 @default.
• W2902060873 cites W2054197933 @default.
• W2902060873 cites W2059107557 @default.
• W2902060873 cites W2059121736 @default.
• W2902060873 cites W2060173830 @default.
• W2902060873 cites W2066847273 @default.
• W2902060873 cites W2073272200 @default.
• W2902060873 cites W2074353251 @default.
• W2902060873 cites W2075028026 @default.
• W2902060873 cites W2085128107 @default.
• W2902060873 cites W2087025400 @default.
• W2902060873 cites W2090978928 @default.
• W2902060873 cites W2098276532 @default.
• W2902060873 cites W2110062192 @default.
• W2902060873 cites W2119706375 @default.
• W2902060873 cites W2124542794 @default.
• W2902060873 cites W2144477621 @default.
• W2902060873 cites W2144749256 @default.
• W2902060873 cites W2151794005 @default.
• W2902060873 cites W2151929770 @default.
• W2902060873 cites W2154409238 @default.
• W2902060873 cites W2156294642 @default.
• W2902060873 cites W2162166699 @default.
• W2902060873 cites W2163887522 @default.
• W2902060873 cites W2166600234 @default.
• W2902060873 cites W2172002311 @default.
• W2902060873 cites W278411638 @default.
• W2902060873 doi "https://doi.org/10.1371/journal.pone.0203874" @default.
• W2902060873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6150501" @default.
• W2902060873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240401" @default.
• W2902060873 hasPublicationYear "2018" @default.
• W2902060873 type Work @default.
• W2902060873 sameAs 2902060873 @default.
• W2902060873 citedByCount "17" @default.
• W2902060873 countsByYear W29020608732019 @default.
• W2902060873 countsByYear W29020608732020 @default.
• W2902060873 countsByYear W29020608732021 @default.
• W2902060873 countsByYear W29020608732022 @default.
• W2902060873 countsByYear W29020608732023 @default.
• W2902060873 crossrefType "journal-article" @default.
• W2902060873 hasAuthorship W2902060873A5000092448 @default.
• W2902060873 hasAuthorship W2902060873A5000373583 @default.

• next